Karthick Vishwanathan, PhD

Senior Director, Head of US Oncology, Clinical Pharmacology and Pharmacometrics
AstraZeneca plc

Poster(s):

• 019: Clinical Pharmacology Insights into Dosing Strategies of Approved Antibody-Drug Conjugates
  Sunday, September 8, 2024

  5:00 PM – 7:00 PM ET

• 026: Phase I Open Label Study to Evaluate the Effects of Savolitinib on the Pharmacokinetics of P-gp, OATP1B1/3, OCT2, MATE1/2K & OAT1/3 Substrates in Healthy Volunteers
  Sunday, September 8, 2024

  5:00 PM – 7:00 PM ET

• 127: Phase I Open Label Study to Evaluate the Effects of Strong CYP1A2 Inhibitor on Savolitinib Pharmacokinetics in Healthy Volunteers
  Monday, September 9, 2024

  5:00 PM – 7:00 PM ET